HIGHLIGHTS
- who: Giulia Pinton from the Frontiers Media SA, Switzerland Department of Pharmaceutical Sciences, University of Piemonte Orientale (UPO), Novara, Italy have published the paper: Corrigendum: CDKN2A determines mesothelioma cell fate to EZH2 inhibition, in the Journal: (JOURNAL)
SUMMARY
Malignant pleural mesothelioma, EZH2 inhibitor, CDKN2A/p16 i n k 4 a, TG2, multicellular spheroids A corrigendum on CDKN2A determines mesothelioma cell fate to EZH2 inhibition COPYRIGHT by Pinton G, Wang Z, Balzano C, Missaglia S, Tavian D, Boldorini R, Fennell DA, Griffin M and Moro L. In the original article, there was an error . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.